(Q33288884)

25 July 2017

title

A prospective study of monitoring practices for metabolic disease in antipsychotic-treated community psychiatric patients (English)

1 reference

25 July 2017

1 reference

Paul Mackin

1

1 reference

25 July 2017

David R Bishop

series ordinal

2

1 reference

25 July 2017

Helen M O Watkinson

series ordinal

3

1 reference

25 July 2017

publication date

25 June 2007

1 reference

25 July 2017

1 reference

25 July 2017

volume

7

1 reference

25 July 2017

page(s)

28

1 reference

Creative Commons Attribution 2.0 Generic

25 July 2017

copyright license

start time

25 June 2007

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

exact match

https://scigraph.springernature.com/pub.10.1186/1471-244x-7-28

0 references

cites work

Minimising metabolic and cardiovascular risk in schizophrenia: diabetes, obesity and dyslipidaemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1913512

Metabolic monitoring for patients treated with antipsychotic medications

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1913512

Low rates of treatment for hypertension, dyslipidemia and diabetes in schizophrenia: data from the CATIE schizophrenia trial sample at baseline

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1913512

Prevalence of diabetes, metabolic syndrome and metabolic abnormalities in schizophrenia over the course of the illness: a cross-sectional study

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1913512

Metabolic syndrome--a new world-wide definition. A Consensus Statement from the International Diabetes Federation

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1913512

Metabolic abnormalities associated with second generation antipsychotics: fact or fiction? Development of guidelines for screening and monitoring

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1913512

Clustering of metabolic comorbidity in schizophrenia: a genetic contribution?

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1913512

Effectiveness of antipsychotic drugs in patients with chronic schizophrenia

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1913512

Physical health of people with severe mental illness

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1913512

Causes of the excess mortality of schizophrenia

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1913512

Correct homeostasis model assessment (HOMA) evaluation uses the computer program

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1913512

Excess mortality of schizophrenia. A meta-analysis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1913512

The influence of body fat distribution on the incidence of diabetes mellitus. 13.5 years of follow-up of the participants in the study of men born in 1913.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1913512

Testing for diabetes in hospitalised patients prescribed antipsychotic drugs

21 June 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1471-244X-7-28

Prevalence of obesity, glucose homeostasis disorders and metabolic syndrome in psychiatric patients taking typical or atypical antipsychotic drugs: a cross-sectional study

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1471-244X-7-28

Hyperglycemia and diabetes in patients with schizophrenia or schizoaffective disorders.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1471-244X-7-28

Family history of type 2 diabetes in schizophrenic patients

21 January 2018

1 reference

12 December 2020

Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group

1 reference

12 December 2020

Abdominal adiposity and coronary heart disease in women

1 reference

12 December 2020

Consensus development conference on antipsychotic drugs and obesity and diabetes

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-244X-7-28

1 reference

Dimensions Publication ID

25 July 2017

1 reference

https://scigraph.springernature.com/pub.10.1186/1471-244x-7-28

9 September 2019

1 reference

25 July 2017

1 reference